PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOPP.L Regulatory News (OPP)

  • There is currently no data for OPP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Schedule 1 - Origo Sino-India Plc

27 Nov 2009 09:51

RNS Number : 1940D
AIM
27 November 2009
 



ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM RULES")

COMPANY NAME:

Origo Sino-India plc

COMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY TRADING ADDRESS (INCLUDING POSTCODES) :

4th Floor

One Circular Road

Douglas

Isle of Man

IM99 3NZ

COUNTRY OF INCORPORATION:

Isle of Man

COMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION REQUIRED BY AIM RULE 26:

www.origoplc.com

COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTING POLICY) IF THE ADMISSION IS SOUGHT AS A RESULT OF A REVERSE TAKE-OVER UNDER RULE 14, THIS SHOULD BE STATED:

The merger of Origo Resource Partners plc and Origo Sino-India plc (the "Company") is considered reverse take-over under AIM Rule 14.

Investing policy

The Company invests predominately in privately held companies across various sectors of

China's economy, and in companies and assets with connections to the Chinese market, with the Company's objective being to provide shareholders with above market returns, primarily through capital appreciation.

In terms of stage, the Company generally pursues three kinds of opportunities:

• investments in pre-IPO opportunities, where the Company can add value through providing assistance in relation to restructuring, international expansion and the listing on a domestic or foreign stock exchange;

• profitable, expansion stage companies requiring financing to meet working capital requirements, expansion capital and/or as capital to finance merger and acquisition opportunities; and

• selected earlier-stage companies, which demonstrate compelling prospects for fast-growth and paths to profitability.

At its present level of capitalisation, the Company is unlikely to commit in excess of $20 million to any single investee company at the time of investment. For early-stage opportunities, initial commitments may be less than $1 million. While the Company does not have any set gearing policy (although it does not expect to be highly geared at an enlarged group level) investee companies, directly or indirectly, may themselves have outstanding borrowings. The Company currently carries out its own commercial due diligence in respect of potential investments (and engages professional advisers for specialised tasks such as legal, financial and technical due diligence) but may outsource this process over time.

In addition to investing predominately in privately held companies, the Company may, in its absolute discretion, hold or invest in publicly traded shares, quasi-equity and/or debt instruments, including convertible or non-convertible debt securities coupled with warrants and/or options, which may or may not represent shareholding or management control. The Company plans to allocate no more than 20 per cent. of available cash resources to investment in publicly traded equities.

The Company seeks to be an active investor and to make minority investments. To the extent possible, minority investments are structured so as to ensure adequate minority protection rights, including but not limited to board participation (via a board director/observer), membership of supervisory, audit and oversight committees, as well as specific veto rights over key corporate decisions.  In addition, the Company generally dedicates at least one other nominee who, together with the board director/observer, is responsible for assisting the investee company on matters such as building and augmenting the management team, implementing relevant corporate governance and financial control procedures, defining and executing a growth and financing strategy, introducing suitable partners and business opportunities and matters related to future fund-raisings, acquisitions or exit considerations.

The holding period for investments is expected to vary depending on the type of investment, the particular circumstances of the relevant investee company, and the intended exit route. The holding period for pre-IPO and expansion stage investments is targeted at between 9 and 24 months and for earlier stage investments at between 24 and 48 months. There is currently a limited spread of investments but this may change if the Company raises additional debt or equity capital.

DETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY RESTRICTIONS AS TO TRANSFER OF THE SECURITIES (i.e. where known, number and type of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares):

Ordinary Shares of £0.0001 each. Number of shares - TBC

CAPITAL TO BE RAISED ON ADMISSION (IF APPLICABLEAND ANTICIPATED MARKET CAPITALISATION ON ADMISSION:

No capital to be raised; anticipated market capitalisation - TBC

PERCENTAGE OF AIM SECURITIES NOT IN PUBLIC HANDS AT ADMISSION:

TBC

DETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM TO WHICH THE AIM COMPANY HAS APPLIED OR AGREED TO HAVE ANY OF ITS SECURITIES (INCLUDING ITS AIM SECURITIESADMITTED OR TRADED:

None

FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS (underlining the first name by which each is known or including any other name by which each is known):

Chris Andre Rynning (Chief Executive Officer)

Karl Niklas Ponnert (Chief Financial Officer)

Wang Chao Yong (Executive Chairman)

Christopher Martin Jemmett (Non-Executive Director)

Dipankar Basu (Non-Executive Director)

FULL NAMES AND HOLDINGS OF SIGNIFICANT SHAREHOLDERS EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL, BEFORE AND AFTER ADMISSION (underlining the first name by which each is known or including any other name by which each is known):

Currently

GLG Partners LP - 29.59%

British Steel Pensions - 5.51%

Origo Sino-India Employee Benefit Trust - 5.23%

Merrill Lynch 5.10%

Bullfrog Holdings Limited 4.97%

Nortrust Nominees Limited 4.70%

Progressive Asset Management - 4.16%

Wellington Management Company - 3.58%

After Admission

TBC

NAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES:

Each of the following persons being consultants and contractors to the Company has received those fees detailed below from the Company within the 12 months prior to 10 November 2009

Aura Financial LLP 

Capita Registrars Limited 

City Continental Finance 

Dougherty Quinn Limited 

Jiayou International Holdings Ltd 

Jonathan Leslie 

Salzer Consulting Pte Ltd 

Seymour Pierce Limited 

Sinohigh Investment Corporation 

Summit Global Holdings Limited 

ANTICIPATED ACCOUNTING REFERENCE DATE 

DATE TO WHICH THE MAIN FINANCIAL INFORMATION IN THE ADMISSION DOCUMENT HAS BEEN PREPARED (this may be represented by unaudited interim financial information)

DATES BY WHICH IT MUST PUBLISH ITS FIRST THREE REPORTS PURSUANT TO AIM RULES 18 AND 19:

(i) 31 December

(ii) 30 June 2009

(iii) 30 June 2010, 30 September 2010 and 30 June 2011

EXPECTED ADMISSION DATE:

14 December 2009

NAME AND ADDRESS OF NOMINATED ADVISER:

Smith & Williamson Corporate Finance Limited

25 Moorgate

London

EC2R 6AY

NAME AND ADDRESS OF BROKER:

Liberum Capital Limited

CityPoint

10th Floor

One Ropemaker Street

London

EC2Y 9HT

OTHER THAN IN THE CASE OF A QUOTED APPLICANTDETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES:

Smith & Williamson Corporate Finance Limited

25 Moorgate

London

EC2R 6AY

DATE OF NOTIFICATION:

27 November 2009

NEW/ UPDATE:

New

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PAAGCBDBCSDGGCR
Date   Source Headline
16th Jun 20088:00 amRNSDirectorate Change
30th May 200810:03 amRNSFinal Results
16th Apr 20087:00 amRNSNew appointment
10th Apr 20084:30 pmRNSAssignment of loan
31st Mar 20082:59 pmRNSTotal Voting Rights
31st Mar 20082:54 pmRNSResult of EGM
13th Mar 20088:00 amRNSGrant of options
13th Mar 20087:01 amRNSFurther investments
13th Mar 20087:00 amRNSPlacing and trading update
27th Feb 20082:38 pmRNSPlacing and adviser change
28th Jan 20087:00 amRNSCompletion of investments
10th Dec 200710:32 amRNSExercisability of warrants
10th Dec 20079:33 amRNSUS$100 million Fund Launch
20th Nov 200711:45 amRNSPrivate Equity Fund
9th Oct 200710:07 amRNSCompany Update
20th Sep 20077:01 amRNSInterim Results
19th Sep 20079:33 amRNSDirectorate Change
4th Sep 20077:01 amRNSRe Agreement
28th Aug 20079:14 amRNSIncrease in holding
17th Aug 20073:34 pmRNSAIM Rule 26
10th Aug 20079:06 amRNSEverest Kanto engage Origo
25th Jul 200710:13 amRNSInvestment
13th Jul 20073:00 pmRNSNotice of AGM
29th Jun 20077:01 amRNSAnnual Report and Accounts
22nd Jun 20074:25 pmRNSFinal Results - correction
22nd Jun 20077:33 amRNSLetter of Intent Signed
22nd Jun 20077:01 amRNSFinal Results
14th Jun 200711:35 amRNSInvestment in Fans Media
31st May 200711:32 amRNSIssue of convertible notes
24th May 200712:41 pmRNSIssue of Loan Note
17th May 20079:17 amRNSIssue of Convertible Note
16th May 20079:56 amRNSMajor interest in shares
11th May 20071:32 pmRNSStmnt re Share Price Movement
24th Apr 200710:56 amRNSAppointment
4th Apr 200710:03 amRNSStatement re Investment
2nd Apr 200712:07 pmRNSExchange of Shares
20th Mar 200710:33 amRNSHolding(s) in Company
13th Mar 20077:01 amRNSHolding(s) in Company
12th Mar 200710:28 amRNSInvestment in company
8th Mar 20079:46 amRNSInvestment
7th Mar 200711:20 amRNSInvestment in Company
27th Feb 20073:54 pmRNSHolding(s) in Company
27th Feb 20079:26 amRNSInvestment
19th Jan 20071:07 pmRNSTotal Voting Rights
12th Jan 20079:49 amRNSRe: Investment
11th Jan 20079:41 amRNSInvestment Agreement
21st Dec 200610:50 amRNSAdmission to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.